from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3644c/-

LFCtreatmentdescriptionclass of inhibitor

-1.412

Amikacinug/mL Amikacintranslation

-1.178

Cap5-10ug/mL Capreomycintranslation

-1.219

Rox10-50 ug/mL Roxithromycintranslation

-0.493

SM2-5 ug/mL Streptomycintranslation

-0.632

Tet5-10 ug/mL Tetracyclinetranslation

-1.314

Rif0.2-5ug/mL Rifampicintranscription

-0.375

Rifp0.1-0.5ug/mL Rifapentinetranscription

2.238

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.078

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.508

CPZ10-50 ug/mL Chlorpromazinerespiration

0.873

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.109

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.702

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.184

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.151

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.011

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.507

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.033

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.649

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.809

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.710

KCN5-20 ug/mL Potassium cyaniderespiration

-0.551

NaN30.2-2 mM Sodium aziderespiration

-0.545

Nigericin50 uM Nigericinrespiration

-0.163

TRC10-150 ug/mL Triclosanrespiration

-0.263

TRZ10-25 ug/mL Thioridazinerespiration

0.425

Valinomycin0.5-10 uM Valinomycinrespiration

1.296

ZnSO42 mM ZnSO4respiration

0.834

menadione6-10 ug/mL Menadionerespiration

0.746

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.071

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.741

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.242

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.713

NRP_1Non-replicating persistence stage 1dosRassociated

0.287

Amp0.2mg/mL AmpicillincellWall

-0.490

Cephalexin20-100 ug/mL CephalexincellWall

-0.539

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.493

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.458

EMB10-20 ug/mL EthambutolcellWall

-0.165

Eta12-40 ug/mL EthionamidecellWall

-0.311

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.890

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.576

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.243

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.280

BZA0.12 mg/mL BenzamidearomaticAmides

0.520

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.202

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.144

H2O24 mM hydrogen peroxideDNAdamaging

1.552

Levo10 ug/mL LevofloxacinDNAdamaging

0.140

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.323

Novobiocin10 ug/mL NovobiocinDNAdamaging

2.465

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.505

UVUV-irradiationDNAdamaging

0.725

ARP41-4 ug/mL Antitubercular compound ARP4?

1.056

Antimycin12.5-50 ug/mL Antimycin A?

-0.025

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.090

PA_110-50 ug/mL Antitubercular compound PA-1?

0.247

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.181

PA8240.2-2 ug/mL PA-824?

-0.233

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-1.086

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.629

Verapamil50 uM Verapamil?

0.290

mercaptoethanol2 mM 2-Mercaptoethanol?

0.229

methoxatin10-20 ug/mL Methoxatin?